Clinical Trial

National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group

Study acronym: BCB-Sarcomes
Recruiting
View on ClinicalTrials.gov →
Summary
The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas \[RESOS\] / French expert network dedicated to the pathology of sarcomas \[RREPS\]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS / French expert clinical network for sarcomas \[NETSARC\]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE / BONE / GIST) is dedicated to collecting patients longitudinal/follow up data, with a focus on treatments of every events, and a catalogue of associated samples. Primary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes. With the financial support of the French National Cancer Institute \[Institut National du cancer \[INCa\]).
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2019-06-05; most recent amendment 2025-08-28.
Trial Details
NCT Number NCT03978039
Lead Sponsor Institut Bergonié
Collaborators: French Sarcoma Group
Conditions Sarcoma
Enrollment 150,000 participants
Start Date 2010-01-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-04